Laura P. Serwer
Affiliations: | Neurological Surgery | University of California, San Francisco, San Francisco, CA |
Google:
"Laura Serwer"Parents
Sign in to add mentorC. David James | grad student | 2011 | UCSF | |
(Investigating the Use of Protein and Liposomal Therapeutics for the Treatment of Glioblastoma.) |
BETA: Related publications
See more...
Publications
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
Krtolica A, Moan NL, Getz J, et al. (2015) Abstract 3003: OMX-4.80P, a novel H-NOX oxygen carrier that oxygenates hypoxic tumors in multiple tumor models and canine cancer patients, downregulates HIF-1 pathway and increases response to radiation therapy leading to cures Cancer Research. 75: 3003-3003 |
Serwer L, Le Moan N, Regan M, et al. (2015) NIMG-45REAL-TIME PET IMAGING DEMONSTRATES TUMOR ACCUMULATION AND OXYGENATION BY OMX-4.80P, AN OXYGEN CARRIER ENGINEERED FOR THE TREATMENT OF GLIOBLASTOMA Neuro-Oncology. 17: v164.1-v164 |
Leung P, Le Moan N, Getz J, et al. (2015) ATPS-49RESULTS OF A PHASE 0 CLINICAL TRIAL IN CANINE BRAIN CANCER EVALUATING SAFETY AND ACTIVITY OF OMX-4.80P, A PROTEIN OXYGEN CARRIER IND CANDIDATE FOR TREATMENT OF GLIOBLASTOMA Neuro-Oncology. 17: v29.1-v29 |
Le Moan N, Getz J, Ng S, et al. (2014) ET-32 * HYPOXIA REDUCTION IN INTRACRANIAL GLIOBLASTOMA MODELS BY OMX-4.80P, A PEGylated ENGINEERED H-NOX OXYGEN CARRIER THAT IS LONG-LASTING IN CIRCULATION AND SAFE Neuro-Oncology. 16: v86-v86 |
Krtolica A, Le Moan N, Getz J, et al. (2014) ET-31 * RADIOSENSITIZATION BY OMX-4.80P, A PEGylated H-NOX OXYGEN CARRIER THAT PENETRATES AND OXYGENATES HYPOXIC TUMORS, IN PRECLINICAL MODELS OF GLIOBLASTOMA AND OTHER HYPOXIC CANCERS Neuro-Oncology. 16: v86-v86 |
Krtolica A, Le Moan N, Serwer L, et al. (2014) O2.04 * TREATMENT WITH OMX-4.80, A TUMOR-PENETRATING TUNABLE OXYGEN CARRIER, REDUCES TUMOR HYPOXIA AND DRAMATICALLY ENHANCES RADIATION THERAPY IN INTRACRANIAL MODELS OF GLIOBLASTOMA Neuro-Oncology. 16: ii3-ii4 |
Weng KC, Hashizume R, Noble CO, et al. (2013) Convection-enhanced delivery of targeted quantum dot-immunoliposome hybrid nanoparticles to intracranial brain tumor models. Nanomedicine (London, England). 8: 1913-25 |
Aaberg-Jessen C, Fogh L, Halle B, et al. (2013) EXPERIMENTAL THERAPEUTICS AND PHARMACOLOGY Neuro-Oncology. 15: iii37-iii61 |
Serwer LP, James CD. (2012) Challenges in drug delivery to tumors of the central nervous system: an overview of pharmacological and surgical considerations. Advanced Drug Delivery Reviews. 64: 590-7 |
Serwer LP, Noble CO, Michaud K, et al. (2011) Investigation of intravenous delivery of nanoliposomal topotecan for activity against orthotopic glioblastoma xenografts. Neuro-Oncology. 13: 1288-95 |